Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma
Annals of Gastroenterological Surgery · 2023-11 · 7 (6) · 977-986
DOI: 10.1002/ags3.12686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Gastroenterological Surgery, online erschienen am 24.04.2023. Verfasst von Tomonari Shimagaki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery National Hospital Organization Kyushu Cancer Center Fukuoka Japan. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
This study was performed to investigate the relationship between the preoperative cachexia index (CXI) and long‐term outcomes in patients who have undergone radical resection of pancreatic ductal adenocarcinoma (PDAC).
Methods
In total, 144 patients who underwent pancreatic resection for treatment of PDAC were retrospectively analyzed. The relationship between the CXI and the patients' long‐term outcomes after PDAC resection was investigated. The CXI was calculated based on the preoperative skeletal muscle index, serum albumin level, and neutrophil‐to‐lymphocyte ratio. After propensity‐score matching, we compared clinicopathological features and outcomes.
Results
The multivariate analysis showed that lymph node metastasis (hazard ratio [HR], 1.93; 95% confidence interval [CI], 1.16–3.23; P = 0.0118), R1 resection (HR, 57.20; 95% CI, 9.39–348.30; P < 0.0001), and a low CXI (HR, 2.10; 95% CI, 1.27–3.46; P = 0.0038) were independent and significant predictors of disease‐free survival (DFS) after PDAC resection. Moreover, a low CXI (HR, 3.14; 95% CI, 1.71–5.75; P = 0.0002) was an independent and significant predictor of overall survival (OS) after PDAC resection. After propensity‐score matching, the low CXI group had a significantly worse prognosis than the high CXI group for both DFS and OS.
Conclusion
The CXI can be a useful prognostic factor for DFS and OS after pancreatic resection for treatment of PDAC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery National Hospital Organization Kyushu Cancer Center Fukuoka Japan.
- Department of Gastroenterological Surgery National Hospital Organization Kyushu Cancer Center Fukuoka Japan.
ORCID-Profile: Tomonari Shimagaki, Tomohiro Iguchi, Masahiko Sugiyama
Zitieren
APA
Shimagaki, T., Sugimachi, K., Mano, Y., Onishi, E., Iguchi, T., Nakashima, Y., Sugiyama, M., Yamamoto, M., Morita, M., & Toh, Y. (2023). Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma. Annals of Gastroenterological Surgery, 7(6), 977-986. https://doi.org/10.1002/ags3.12686
Vancouver
Shimagaki T, Sugimachi K, Mano Y, Onishi E, Iguchi T, Nakashima Y, et al. Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma. Annals of Gastroenterological Surgery. 2023;7(6):977-986. doi:10.1002/ags3.12686
BibTeX
@article{Shimagaki2023,
author = {Shimagaki, Tomonari and Sugimachi, Keishi and Mano, Yohei and Onishi, Emi and Iguchi, Tomohiro and Nakashima, Yuichiro and Sugiyama, Masahiko and Yamamoto, Manabu and Morita, Masaru and Toh, Yasushi},
title = {Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma},
journal = {Annals of Gastroenterological Surgery},
year = {2023},
volume = {7},
number = {6},
pages = {977--986},
doi = {10.1002/ags3.12686}
}
EUVIMED